Title |
A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO) |
|---|---|
Involved |
Isabel Virchow (Verfasser)
Jürgen-Walter Treckmann (Verfasser) Nicole Prasnikar (Verfasser) Gabriele Linden (Verfasser)
Peter Markus (Verfasser)
Brigitte Schumacher (Verfasser) David Albers (Verfasser) Thomas Herold (Verfasser) Saskia Carolin Ting (Verfasser) Hartmut Schmidt (Verfasser) Sonja Radunz (Verfasser) Marcel Wiesweg (Verfasser) Jens Siveke (Verfasser) Martin Schuler (Verfasser) Stefan Kasper-Virchow (Verfasser) |
Published in |
Oncology research and treatment 46, 3, 2023, Seite 89-99 |
Published |
09.01.2023 |
Language |
|
Country |
|
Topic |
|
Subject |
Cholangiocarcinoma |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2023031523250163641615 (URN) |
Record ID |
1283551985 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: